A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to obtain an assessment (efficacy, safety, and patient reported
outcomes) of basal bolus insulin delivery with PaQ in insulin-using patients with type 2
diabetes mellitus (T2DM).